
Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) – Stock analysts at HC Wainwright cut their Q2 2026 earnings per share estimates for Sintx Technologies in a report released on Wednesday, May 20th. HC Wainwright analyst B. Folkes now forecasts that the company will earn ($0.81) per share for the quarter, down from their previous estimate of ($0.78). HC Wainwright currently has a “Buy” rating and a $10.00 target price on the stock. The consensus estimate for Sintx Technologies’ current full-year earnings is ($2.16) per share. HC Wainwright also issued estimates for Sintx Technologies’ Q3 2026 earnings at ($0.43) EPS, Q4 2026 earnings at ($0.50) EPS, FY2026 earnings at ($2.27) EPS, FY2027 earnings at ($1.50) EPS, FY2028 earnings at ($0.74) EPS, FY2029 earnings at $1.37 EPS and FY2030 earnings at $2.06 EPS.
Sintx Technologies (NASDAQ:SINT – Get Free Report) last announced its quarterly earnings results on Friday, May 15th. The company reported ($0.70) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by ($0.04). Sintx Technologies had a negative return on equity of 366.49% and a negative net margin of 1,058.60%.The company had revenue of $0.38 million during the quarter, compared to the consensus estimate of $0.30 million.
Get Our Latest Stock Analysis on SINT
Sintx Technologies Price Performance
Shares of NASDAQ SINT opened at $2.30 on Friday. Sintx Technologies has a 1-year low of $1.99 and a 1-year high of $6.78. The business’s fifty day moving average price is $2.51 and its two-hundred day moving average price is $3.10. The firm has a market capitalization of $9.94 million, a PE ratio of -0.45 and a beta of 0.61.
Institutional Investors Weigh In On Sintx Technologies
A hedge fund recently raised its stake in Sintx Technologies stock. Geode Capital Management LLC grew its holdings in shares of Sintx Technologies, Inc. (NASDAQ:SINT – Free Report) by 33.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,339 shares of the company’s stock after purchasing an additional 3,848 shares during the period. Geode Capital Management LLC owned approximately 0.56% of Sintx Technologies worth $49,000 as of its most recent filing with the Securities and Exchange Commission. 18.38% of the stock is owned by hedge funds and other institutional investors.
Sintx Technologies Company Profile
Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.
The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.
Featured Stories
- Five stocks we like better than Sintx Technologies
- Meta Platforms 10% Layoff Raises a Bigger Question About AI Spending
- As Small-Cap Outperformance Continues, These 2 ETFs Provide Exposure
- Silicon Shake-Up: The AI Trade Is Moving Beyond NVIDIA
- The Silver Lining of Last Week’s Hims & Hers Earnings Miss
Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
